Aurobindo Pharma Ltd gets 1 observation from USFDA

The United States Food and Drug Administration (US FDA) inspected Unit-VII, an API manufacturing facility, of Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma Ltd, situated at Parwada Mandal, Anakapally District, Andhra Pradesh from May 5 to 10, 2024.

The inspection closed with 1 observation. The observation is of procedural in nature and will be responded to within the stipulated time.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1136.00 as compared to the previous close of Rs. 1124.75. The total number of shares traded during the day was 30116 in over 2089 trades.

The stock hit an intraday high of Rs. 1145.00 and intraday low of 1110.15. The net turnover during the day was Rs. 34035352.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 ApitoriaPharma USFDA Inspection 1Observation